Barclays Cuts HCA Healthcare (NYSE:HCA) Price Target to $387.00

HCA Healthcare (NYSE:HCA) had its price target cut by Barclays from $402.00 to $387.00 in a research note issued to investors on Monday, Marketbeat reports. They currently have an equal weight rating on the stock.

A number of other brokerages also recently issued reports on HCA. Wall Street Zen downgraded HCA Healthcare from a “buy” rating to a “hold” rating in a report on Saturday, May 2nd. Raymond James Financial set a $528.00 price target on HCA Healthcare in a research report on Tuesday, July 7th. Sanford C. Bernstein restated a “market perform” rating on shares of HCA Healthcare in a research note on Wednesday, July 15th. Robert W. Baird dropped their target price on HCA Healthcare from $396.00 to $393.00 and set a “neutral” rating on the stock in a report on Monday. Finally, Truist Financial set a $413.00 target price on shares of HCA Healthcare in a report on Thursday, June 4th. Fourteen analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $465.05.

HCA Healthcare Stock Down 2.3%

Shares of HCA opened at $408.39 on Monday. HCA Healthcare has a fifty-two week low of $342.71 and a fifty-two week high of $556.52. The company has a market cap of $90.60 billion, a P/E ratio of 13.67, a PEG ratio of 1.46 and a beta of 1.12. The firm’s 50 day moving average price is $386.80 and its 200 day moving average price is $452.03.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings data on Friday, July 24th. The company reported $7.59 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.56 by $0.03. The business had revenue of $20.23 billion during the quarter, compared to analysts’ expectations of $19.76 billion. HCA Healthcare had a negative return on equity of 244.79% and a net margin of 8.77%.The business’s quarterly revenue was up 8.7% compared to the same quarter last year. During the same quarter last year, the business posted $6.84 EPS. Research analysts forecast that HCA Healthcare will post 29.38 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 30th. Stockholders of record on Wednesday, September 16th will be paid a dividend of $0.78 per share. This represents a $3.12 dividend on an annualized basis and a dividend yield of 0.8%. The ex-dividend date of this dividend is Wednesday, September 16th. HCA Healthcare’s dividend payout ratio (DPR) is 10.45%.

Institutional Trading of HCA Healthcare

A number of hedge funds have recently bought and sold shares of HCA. Palisade Asset Management LLC purchased a new position in shares of HCA Healthcare during the 3rd quarter worth $26,000. Ares Financial Consulting LLC purchased a new position in HCA Healthcare during the fourth quarter worth approximately $31,000. Cedar Mountain Advisors LLC purchased a new stake in HCA Healthcare during the first quarter valued at about $33,000. JPL Wealth Management LLC purchased a new position in HCA Healthcare in the third quarter valued at approximately $33,000. Finally, MCF Advisors LLC increased its holdings in HCA Healthcare by 213.0% in the 4th quarter. MCF Advisors LLC now owns 72 shares of the company’s stock valued at $34,000 after purchasing an additional 49 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

More HCA Healthcare News

Here are the key news stories impacting HCA Healthcare this week:

• Positive Sentiment: HCA’s stock outperformed peers during a broadly strong trading session, suggesting some investor support despite recent concerns. HCA stock outperforms competitors
• Positive Sentiment: RBC reiterated its “Outperform” rating, while Mizuho maintained an “Outperform” view and set a $475 price target, implying substantial upside from the recent trading level. RBC reiterates Outperform Mizuho price target
• Positive Sentiment: HCA appointed experienced executives to lead two Tampa hospitals, including a former Oak Hill Hospital executive, and named Jordan Fulkerson chief financial officer of HCA Florida Memorial Hospital. The moves may support local operating continuity. Tampa hospital leadership appointments Memorial Hospital CFO appointment
• Neutral Sentiment: KeyCorp, Truist, and Baird lowered or tempered their HCA price expectations, although the changes reflect analyst caution rather than a broad withdrawal of coverage. KeyCorp set a $435 target, while RBC remained positive. KeyCorp lowers price target Baird forecast Truist price outlook
• Negative Sentiment: A judge rejected a key HCA argument concerning its obligations to provide services at Mission Hospital. Separately, Dogwood Health Trust reported potential noncompliance with the contract governing HCA’s Mission Health acquisition. These developments raise the risk of additional costs, enforcement actions, or operating restrictions. Mission Hospital court ruling Mission contract compliance concerns
• Negative Sentiment: Pomerantz announced an investigation into potential investor claims involving HCA, adding legal overhang and possible reputational risk, although the announcement does not establish wrongdoing. Pomerantz investor investigation

HCA Healthcare Company Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.